Publications - 'C'

Publications 951 - 975 de 2875
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) predictive value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: Results of a prospective cohort from the French Breast Cancer In
J.Y. Pierga; A. Silveira; V. Lorgis; M.L. Tanguy; O. Tredan; C. Dubot; W. Jacot; A. Goncalves; M. Debled; C. Levy; J.M. Ferrero; C. Jouannaud; E. Luporsi; M.A. Mouret-Reynier; F. Dalenc; J. Lemonnier; F. Berger; C. Proudon; F.C. Bidard
2019
10.1158/1538-7445.SABCS18-PD2-03
Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF plus Non-Small Cell Lung Cancer
S. Ortiz-Cuaran; L. Mezquita; A. Swalduz; M. Aldea; J. Mazieres; C. Jovelet; W.R.Chumbi Flores; L. Lacroix; Y. Loriot; L. Friboulet; V. Westeel; M. Ngocamus; A. Pradines; C. Tissot; C. Duchene; C. Raynaud; X. Quantin; R. Gervais; E. Brain; I. Monnet; G. Leprieur; V. Avrillon; M.A. Oukhatar; N. Hoog-Labouret; F. De Kievit; K. Howarth; J. Guichou; C. Morris; E. Green; M. Perol; B. Besse; J. Blay; P. Saintigny; D. Planchard
2019
10.1016/j.jtho.2019.08.678
Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial
F.C. Bidard; M. Ychou; J. Madic; A. Saliou; O. Bouche; M. Rivoire; F. Ghiringhelli; E. Francois; R. Guimbaud; L. Mineur; F. Khemissa-Akouz; T. Mazard; D. Moussata; W. Cacheux; C. Proudhon; M.H. Stern; J.Y. Pierga; T. Stanbury; S. Thezenas; P. Mariani
2016
10.1093/annonc/mdw370.5
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer
S. Ortiz-Cuaran; L. Mezquita; A. Swalduz; M. Aldea; J. Mazieres; C. Leonce; C. Jovelet; A. Pradines; V. Avrillon; W.R.Chumbi Flores; L. Lacroix; Y. Loriot; V. Westeel; M. Ngo-Camus; C. Tissot; C. Raynaud; R. Gervais; E. Brain; I. Monnet; E.Giroux Leprieur; C. Caramella; C.MahierAit Oukhatar; N. Hoog-Labouret; F. de Kievit; K. Howarth; C. Morris; E. Green; L. Friboulet; S. Chabaud; J.F. Guichou; M. Perol; B. Besse; J.Y. Blay; P. Saintigny; D. Planchard
2020
10.1158/1078-0432.CCR-20-1037
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
D.M. Kurtz; F. Scherer; M.C. Jin; J. Soo; A.F.M. Craig; M.Shahrokh Esfahani; J.J. Chabon; H. Stehr; C.Long Liu; R. Tibshirani; L.S. Maeda; N.K. Gupta; M.S. Khodadoust; R.H. Advani; R. Levy; A.M. Newman; U. Duehrsen; A. Huettmann; M. Meignan; R.O. Casasnovas; J.R. Westin; M. Roschewski; W.H. Wilson; G. Gaidano; D. Rossi; M. Diehn; A.A. Alizadeh
2018
10.1200/JCO.2018.78.5246
Circumcision and Risk of Febrile Urinary Tract Infection in Boys with Posterior Urethral Valves: Result of the CIRCUP Randomized Trial
L. Harper; T. Blanc; M. Peycelon; J.L. Michel; M.D. Leclair; S. Garnier; V. Flaum; A.P. Arnaud; T. Merrot; E. Dobremez; A. Faure; L. Fourcade; M.L. Poli-Merol; Y. Chaussy; O. Dunand; F. Collin; L. Huiart; C. Ferdynus; F. Sauvat
2022
10.1016/j.eururo.2021.08.024
Circumscribed myositis ossificans
D. Wendling; M. Chouk; X. Guillot; S. Aubry; C. Prati
2021
10.1016/j.jbspin.2020.105119
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results
D. Thabut; A. Pauwels; N. Carbonell; A.Jean Remy; P. Nahon; X. Causse; J.P. Cervoni; J.F. Cadranel; I. Archambeaud; S. Bramli; F. Ehrhard; P. Ah-Soune; F. Rostain; A. Pariente; J. Vergniol; J.P. Dupuychaffray; A.L. Pelletier; F. Skinazi; A. Guillygomarc'h; R.L. Vitte; J. Henrion; S. Combet; M. Rudler; C. Bureau; C.Francophon Hypertension; A. Hepato-Gastroenterologues
2018
Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma
B. Vanbervliet-Defrance; T. Delaunay; T. Daunizeau; V. Kepenekian; O. Glehen; K. Weber; Y. Estornes; A. Ziverec; L. Djemal; M. Delphin; S. Lantuejoul; G. Passot; M. Gregoire; O. Micheau; C. Blanquart; T. Renno; J.F. Fonteneau; S. Lebecque; K. Mahtouk
2020
10.1016/j.canlet.2019.12.016
Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood
J. Boustani; E.Lauret Mar Joseph; E. Martin; S. Benhmida; B. Lecoester; F. Tochet; C. Mirjolet; C. Chevalier; D. Thibouw; N. Vulquin; S. Servagi; X. Sun; O. Adotevi
2021
10.1186/s12865-021-00429-5
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
F. Fiteni; T. Nguyen; D. Vernerey; M.J. Paillard; S. Kim; M. Demarchi; F. Fein; C. Borg; F. Bonnetain; X. Pivot
2014
10.1002/cam4.299
Cistercians and the transmission of texts (XIII-XVIII centuries)
C. Rey
2019
Cistercians and the transmission of texts (XIII-XVIII centuries)
C. Rey
2019
Citizen Participation and Political Communication in a Digital World Introduction
A. Frame
2016
Citizen Participation and Political Communication in a Digital World Introduction
A. Frame
2016
CITIZENSHIP, UNIVERSALISM AND STOIC COSMOPOLITANISM: THE ROMAN CASE
A. Gonzales
2018
10.20318/ARYS.2018.4557
City size and the risk of being unemployed. Job pooling vs. job competition
C. Gaigne; M. Sanch-Maritan
2019
10.1016/j.regsciurbeco.2019.05.002
City-Product Service System: a Multi-scale Intelligent Engineering Design Approach
Z. Zhang; E. Ostrosi; A.J. Fougeres; J.B. Bluntzer; Y. Liu; F. Pfaender; M.Z. Tzen
2014
10.3233/978-1-61499-440-4-405
Claiming the sea: Bronze Age fortified sites of the north-eastern Adriatic Sea (Cres and Loinj islands, Croatia)
Z. Cuckovic
2017
10.1080/00438243.2017.1341331
Clarkson-McCarthy inequalities with unitary and isometry orbits
J.C. Bourin; E.Y. Lee
2020
10.1016/j.laa.2020.04.019
Class regained. Working classes in French sociology since the `80s
A. Moro
2017
10.13128/cambio-22914
Classic cytotoxic drugs: a narrow path for regulatory approval
X. Pivot
2017
10.1016/S1470-2045(17)30089-X
Classical and molecular methods for identification and quantification of domestic moulds
E. Frealle; V. Bex; G. Reboux; S. Roussel; S. Bretagne
2017
10.1016/j.rmr.2017.01.009
Classical and Quantum Controllability of a Rotating Asymmetric Molecule
E. Pozzoli
2022
10.1007/s00245-022-09821-y
Classical and quantum rotation numbers of asymmetric-top molecules
K. Hamraoui; L. Van Damme; P. Mardesic; D. Sugny
2018
10.1103/PhysRevA.97.032118

Pages